Matsukane, R.; Oyama, T.; Tatsuta, R.; Kimura, S.; Hata, K.; Urata, S.; Watanabe, H.
Real-World Prevalence and Tolerability of Immune-Related Adverse Events in Older Adults with Non-Small Cell Lung Cancer: A Multi-Institutional Retrospective Study. Cancers 2024, 16, 2159.
https://doi.org/10.3390/cancers16112159
AMA Style
Matsukane R, Oyama T, Tatsuta R, Kimura S, Hata K, Urata S, Watanabe H.
Real-World Prevalence and Tolerability of Immune-Related Adverse Events in Older Adults with Non-Small Cell Lung Cancer: A Multi-Institutional Retrospective Study. Cancers. 2024; 16(11):2159.
https://doi.org/10.3390/cancers16112159
Chicago/Turabian Style
Matsukane, Ryosuke, Takahiro Oyama, Ryosuke Tatsuta, Sakiko Kimura, Kojiro Hata, Shuhei Urata, and Hiroyuki Watanabe.
2024. "Real-World Prevalence and Tolerability of Immune-Related Adverse Events in Older Adults with Non-Small Cell Lung Cancer: A Multi-Institutional Retrospective Study" Cancers 16, no. 11: 2159.
https://doi.org/10.3390/cancers16112159
APA Style
Matsukane, R., Oyama, T., Tatsuta, R., Kimura, S., Hata, K., Urata, S., & Watanabe, H.
(2024). Real-World Prevalence and Tolerability of Immune-Related Adverse Events in Older Adults with Non-Small Cell Lung Cancer: A Multi-Institutional Retrospective Study. Cancers, 16(11), 2159.
https://doi.org/10.3390/cancers16112159